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Quantitative correlation of the in vitro biological effect with parameters of molecular complexation in
mutagen-interceptor systems
H I G H L I G H T S
 The quantitative link between biolo-
gical and physico-chemical
parameters is found.
 correction to the known correlation
of biological and phys-chem data is
suggested.
 Mutagen-interceptor systems well
match the theory of interceptor–
protector action.
G R A P H I C A L A B S T R A C T
a r t i c l e i n f o
Keywords:
IQ-type mutagens
Mutagenic test
Interceptor mechanism
Hetero-association
a b s t r a c t
According to the theory of interceptor–protector action a quantitative link between the physico-chemical
parameters of molecular complexation and in vitro biological effect in aromatic drug-interceptor systems
must exist. In the present communication such link between relative change in mutagenicity of IQ-type
aromatic mutagens on addition of aromatic interceptor molecules with equilibrium hetero-association
constants of mutagen-interceptor complexation has been found using the published in vitro data in
bacteria cell systems.
& 2014 Elsevier Ltd. All rights reserved.
1. Introduction
Biological interaction, observed when different aromatic biolo-
gically active compounds are used in combination, has been known
for a long time. The most well-studied combinations of aromatic
molecules are DNA-binding aromatic drugs with xanthines, ribo-
ﬂavin and chlorophyllin (see for reviews Evstigneev (2010, 2013);
Woziwodzka et al. (2013)). It is considered that the administration
of certain aromatic drug (e.g. antitumor antibiotic) along with other
aromatic compound, called ‘interceptor’ (e.g. caffeine or chlorophyl-
lin), can be used for in situ regulation of the toxicity induced by
antibiotic during chemotherapy, or, in some cases, result in ampli-
ﬁcation of medico-biological effects of the antibiotic (Traganos et al.,
1991; Piosik et al., 2002).
Numerous investigations carried out mainly on the in vitro level
have reported that the mechanism of the biological interaction in
drug-interceptor systems may be interpreted in terms of non-
covalent complexation between the molecular components pre-
sent in the mixture, viz. the drug-interceptor hetero-association,
and drug-DNA and interceptor-DNA complexation (Evstigneev,
2010, 2013; Woziwodzka et al., 2013; Traganos et al., 1991;
Piosik et al., 2002). These interactions lie behind the two funda-
mental molecular mechanisms of biological interaction induced
when DNA-binding aromatic drugs are used in combination, viz.
the interceptor (i.e. the drug-interceptor hetero-association) and
protector (i.e. competition of drug and interceptor for DNA-
binding sites) mechanisms. The generalization of this view has
been accomplished within the framework of the theory of inter-
ceptor–protector action (the IPA theory) (Evstigneev, 2010;
Evstigneev et al., 2008; Buchelnikov et al., 2012), which aims to
ﬁnd a quantitative link between the in vitro biological data and
parameters of physico-chemical interactions (concentrations and
equilibrium complexation constants).
So far the IPA theory has been successfully applied to quanti-
ﬁcation of relative change in apoptosis in human leukemia cell
lines induced by administration of antitumor antibiotics together
with caffeine (Evstigneev et al., 2006, 2008, 2011). However, to
date one more set of biological data, well matching the basic
postulates of the IPA theory, has been accumulated, viz. the
antimutagenic action of the interceptor molecules towards aro-
matic mutagens in bacteria cell systems (see for review Piosik et al.
(2003); Woziwodzka et al. (2011); Dashwood and Guo (1993)).
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In the present letter we aim to testify the existence of quantitative
link between the biological and physico-chemical parameters in
mutagen-interceptor systems based on the IPA theory.
2. Discussion
2.1. General approach to quantitation of the in vitro biological data
Let X be the main drug exerting its biological effect via
complexation with DNA (N), and Y be the interceptor molecule
which does not exert any biological effect (or its biological effect
does not interfere with X) and be able to form hetero-complexes
with X. Let φ be the measureable response of a biological system
to the presence of both X and Y, whereas φ0 and φc be the
responses of this system (e.g. percentage of apoptotic cells or
mutagenicity) to the presence of X only, and in the absence of both
drugs, respectively (i.e. positive and negative control values). The
key quantity in the IPA theory is the AD factor
AD ¼
φ0φ
φ0φc
; ð1Þ
which stands for relative change in biological effect of X on
addition of Y (examples of linking the AD factor to biological data
are given in Evstigneev et al. (2006, 2008, 2011)).
The principal assumption associated with the AD factor is a
proportionality between the mole fraction of X-DNA complexes,
f XC , and the observed biological effect, φ. As a consequence of this
assumption, the relative change of biological effect of X on
addition of Y (i.e. the AD factor) may be quantitatively expressed
in terms of relative change in mole fractions of X-DNA complexes
as (Evstigneev et al., 2006, 2008)
AD ¼
f XCð0Þ  f XC
f XCð0Þ
; ð2Þ
where f XCð0Þ is the mole fraction of X-DNA complexes in the absence
of interceptor.
Such deﬁnition of the AD factor sets up a direct link between
the biological (AD or φ) and physico-chemical (f
X
C ) parameters. In
order to utilize this link, the method of computation of the mole
fractions is needed.
The mole fractions in Eq. (2) may be found from the solution of
mass balance equations for the X-Y-DNA system, given in
Evstigneev et al. (2008) in the most simple form as
x1þKhx1y1þKXNx1N1 ¼ x0
y1þKhx1y1þKYNy1N1 ¼ y0
N1þKXNx1N1þKYNy1N1 ¼N0
8><
>: ; ð3Þ
where x1, y1, N1 are the concentrations of free (non-complexed)
drug and interceptor molecules, and DNA binding sites, respec-
tively; x0, y0, N0 are their total concentrations commonly asso-
ciated with the so-called quasi-physiological conditions (N0 ¼ x0,
y0⪢x0 Evstigneev et al. (2006, 2008, 2011)); Kh, KXN, KYN are the
equilibrium constants of hetero-association, X-DNA and Y-DNA
binding, respectively.
Solution of Eq. (3) with respect to x1, y1, N1 enables one to
compute the mole fractions in Eq. (2) as
f XC ¼
KXNx1N1
x0
KYNa0
Kha0
; f XCð0Þ ¼
KXNx1N1
x0
KYN ¼ 0
Kh ¼ 0
: ð4Þ
So, the set of Eqs. (2)–(4) in the IPA theory provides a quantitative
link between the biological and physico-chemical data, which will
be explored below against the mutagenic test in bacteria cell
systems.
2.2. Evaluation of biological data from mutagenic test in mutagen-
chlorophyllin system
Chlorophyllin (CHL) has long been recognized as a molecule
exerting pronounced antimutagenic potency against various aromatic
DNA-actingmutagens (Dashwood and Guo 1993; Pietrzak et al., 2008).
This effect has been interpreted in terms of formation of non-covalent
hetero-complexes between the mutagen and CHL resulting in lower
accessibility of the mutagen to DNA (Woziwodzka et al., 2013;
Dashwood and Guo 1993; Pietrzak et al., 2008) (which is the
interceptor mechanism falling within the competency of the IPA
theory).
The most representative example of the mutagen-chlorophyllin
systems matching the interceptor hypothesis is the antimutagenic
action of CHL against imidazo-quinoline type amines (IQ, 2-amino-
3-methylimidazo[4,5-f]quinoline) in Salmonella typhimurium
strain TA98 reviewed in Dashwood and Guo (1993) by Dashwood.
Statistical treatment of large IQ-CHL dataset had led to a conclu-
sion about a linear correlation between the antimutagenic potency
of chlorophyllin, I50 (which is the chlorophyllin concentration
needed for 50% suppression of mutagenicity in the cell culture
treated with IQ mutagens), and the hetero-association constant of
the formation of IQ-CHL complexes, Kh
I50pKh: ð5Þ
Let us ﬁnd out whether the Eq. (5) may be derived as a partial case
of the IPA theory.
It is known that the IQ-type mutagens directly act on DNA by
means of formation of covalent adducts (Turesky et al., 1992)
which suggests the absence of competition between IQ (X) and
chlorophylline (Y) and, hence, no contribution from the protector
mechanism (i.e. KYN¼0). Corresponding simpliﬁcation of Eq. (3)
yields
x1þKhx1y1þ KXNx11þKXNx1N0 ¼ x0
y1þKhx1y1 ¼ y0
(
: ð6Þ
The solution of Eq. (6) against x1 leads to a third-order algebraic
equation
KhKXNx31þðKhþKXNþKhKXNðy0þN0x0ÞÞx21þ
ð1þKhðy0x0ÞþKXNðN0x0ÞÞx1x0 ¼ 0:
ð7Þ
The typical non-toxic concentrations of the IQ-type mutagens
in the mutagen test fall in the nM-μM range (Woziwodzka et al.,
2011; Dashwood and Guo 1993), so the second- and third-order
terms in Eq. (7) may be neglected. It allows one to get expression
for x1 to be further substituted into Eq. (4) for derivation of the f
X
C
quantities, required for computation of the AD factor in Eq. (2).
Employing the quasi-physiological conditions (N0 ¼ x0, y0⪢x0
Evstigneev et al. (2006, 2008, 2011)) and performing the set of
corresponding mathematical manipulations, the approximate
expression for the AD factor takes the form
AD 
Khy0
1þKhy0
: ð8Þ
Eq. (8) can be further simpliﬁed. Taking into account the typically
micromolar chlorophyllin concentrations in the mutagen test,
y0μM, and the IQ-CHL hetero-association constants, Kh, having
103 M1 order of magnitude (Dashwood and Guo 1993), one can
get Khy0⪡1 in Eq. (8) resulting in expression
AD  Khy0: ð9Þ
Recalling that the biological data in Dashwood and Guo (1993)
were expressed in the form of the I50 factor which is the concentration
of chlorophyllin needed for 50% suppression of mutagenicity in the
mutagen test, the following substitutions are valid, viz. y0  I50 and
AD  1=2. Further transformation of Eq. (9) results in the approximate
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expression for the link between the I50 and Kh factors:
I50 ¼
B
Kh
; ð10Þ
where B is certain constant.
Fitting of the Dashwood data (Fig. 4a in Dashwood and Guo
(1993)) with Eq. (10) shown in Fig. 1 gives much better goodness
of ﬁt (R2¼0.94) as compared with the linear correlation [see Eq.
(5)] (R2¼0.82) initially reported in the cited paper. It means that
the hyperbolic dependence of biological effect (expressed in the
form of the I50 factor) and the physico-chemical parameter of
interaction (expressed in the form of Kh) reﬂects the fundamental
action of the interceptor mechanism in its ‘pure’ form when the
other possible mechanisms (such as the protector, or any other)
contribute negligibly to experimental observable φ. This result is
also supported by the fact that the equilibrium complexation
constants have much higher impact on the value of the AD factor
as compared with other parameters appearing in the system of
mass balance equations (such as Eq. (3)) (Buchelnikov et al.,
2013).
2.3. Evaluation of biological data from mutagenic test in mutagen-
caffeine system
The success in description of the link between the biological
and physico-chemical data in mutagen-chlorophyllin systems
within the framework of the IPA theory suggests that similar
correlation should be observed for other interceptors as well. With
the use of mutagen test in Vibrio harveyi strain A16 the authors of
Woziwodzka et al. (2011) measured the dependence of mutagenic
activity of the IQ-type amines on the concentration of various
xanthines, y0, among which the caffeine (CAF) had exerted the
most pronounced effect (Fig. 8a in Woziwodzka et al. (2011)). Fig. 2
contains the biological data recalculated into AD units according to
Eq. (1), and the AD(y0) dependence computed from Eqs. (2) and (3)
under the sole action of the interceptor mechanism (i.e. KYN¼0)
(the magnitudes of the complexation parameters were taken from
Woziwodzka et al. (2011) and the estimated magnitude of the IQ-
DNA binding was taken as KXN¼2970 M1 from Sartorius and
Schneider (1997)). Small variation of the binding parameters
within 10% range enabled to achieve very good ﬁtting of
experimental data (solid line in Fig. 2) suggesting that the IQ-
CAF systems follow the interceptor mechanism in the same way as
the IQ-CHL systems discussed above.
3. Conclusions
Based on the results of investigation it may be concluded that if
the mechanism of change of biological effect under the use of
aromatic drugs in combination follows the interceptor hypothesis,
this situation may be described within the framework of the
interceptor–protector theory which quantiﬁes the link between
the in vitro biological data and the physico-chemical parameters of
molecular complexation. Previously the existence of such a link
was conﬁrmed for antibiotic-interceptor combinations using
in vitro data in leukemia cell lines (see the introductory section).
In the present work we report the existence of such link with
respect to mutagen-interceptor combinations in bacteria cell
systems. These results are important in terms of managing drug's
response by changing the physico-chemical parameters of mole-
cular complexation and extend scientiﬁc background of rational
drug design.
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